Table 1.
Baseline Demographic, Clinical, Laboratory, and Anthropomorphic Data for Study Participants
| Variable | Overall Population (n=5984) |
|---|---|
| Age (±SD) | 61.9±10.2 |
| Male (%) | 2877 (48%) |
| Follow-up Years, mean±SD | 9.8±1.7 |
| Average Reflection Magnitude, mean±SD | 0.84±0.05 |
| Ethnicity (%) | |
| White | 2247 (38%) |
| Black | 1630 (27%) |
| Chinese | 730 (12%) |
| Hispanic | 1382 (23%) |
| Body Measurements, mean±SD | |
| Height (cm) | 166.4±10.0 |
| Weight (kg) | 78.7±17.3 |
| BMI (kg/m2) | 28.3±5.5 |
| Family History of Heart Attack, n (%) | 2361 (42%) |
| Hypertension, JNC VI Criteria, n (%) | 2675 (45%) |
| Hypertensive Medication Use, n (%) | 2217 (37%) |
| Systolic BP (mm Hg), mean ±SD | 126.5±21.3 |
| Diastolic BP (mm Hg), mean±SD | 72.1±10.2 |
| Heart Rate (bpm), mean±SD | 64.2±10.1 |
| Current Smoking, n (%) | 2162 (36%) |
| Cholesterol Profile (mg/dL), mean±SD | |
| Total Cholesterol | 194.1±35.5 |
| LDL Cholesterol | 117.1±31.4 |
| HDL Cholesterol | 50.8±14.7 |
| Triglycerides | 132.0±83.1 |
| Statin Use, n (%) | 876 (15%) |
| Diabetes, n (%) | 764 (13%) |
| Estimated GFR (mL/min/1.732), mean±SD | 78.2±16.2 |
| Urine Albumin (μg)/Creatinine (mg) Ratio, median (IQR) | 5.3 (3.3, 10.9) |
| C-Reactive Protein (mg/L), median (IQR) | 1.88 (0.82, 4.19) |
| NT-pro-BNP (pg/mL), median (IQR) | 52.64 (23.39, 109.1) |
| Markers of Subclinical Atherosclerosis | |
| Ankle-Brachial Index, mean (±SD) | 1.12±0.12 |
| Mean Agatston Coronary Calcium Score, median (IQR) | 0 (0, 81.39) |
| Maximum Common Carotid Intima- Media Thickness mm, mean±SD | 0.87±0.19 |
| Ascending Aortic Agatston Calcium Score, median (IQR) | 0 (0, 0) |
IQR=interquartile range; SD=standard deviation